CS Diagnostics Corp. (CSDX)
0.0105
0.00 (0.00%)
USD |
OTCM |
Aug 25, 16:00
CS Diagnostics Debt to Equity Ratio : 0.00 for Dec. 31, 2025
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| September 30, 2015 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | |
| December 31, 2008 | 0.00 |
| September 30, 2008 | -0.2184 |
| June 30, 2008 | -0.1355 |
| March 31, 2008 | -0.1384 |
| December 31, 2007 | -0.1253 |
| September 30, 2007 | -0.1038 |
| June 30, 2007 | -0.0776 |
| March 31, 2007 | -0.0273 |
| December 31, 2006 | |
| September 30, 2006 | 0.00 |
| June 30, 2006 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Aibotics, Inc. | -0.2804 |
| GeneDx Holdings Corp. | 0.6855 |
| Ayujoy Herbals Ltd. | -- |
| Arrowhead Pharmaceuticals, Inc. | 2.956 |
| Oncolytics Biotech, Inc. | -0.0726 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 499.49M |
| Total Liabilities (Quarterly) | 0.0153M |
| Shareholders Equity (Quarterly) | 499.47M |
| Current Ratio | 5.595 |